| Sanofi-Aventis (Suisse) SA - Mutagrip, Suspension zur Injektion | | 00373 | | 24 | | Mutagrip | | Suspension zur Injektion | | J07BB02 | | Influenza, gereinigtes Antigen | | 10.09.2015 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) (Virus-Stamm A/California/7/2009 (H1N1)-like: reassortant virus NYMC X-179A) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Switzerland/9715293/2013 (H3N2)-like: reassortant virus IVR-175 derived from A/South Australia/55/2014) 15 µg, haemagglutininum influenzae B (Virus-Stamm B/Phuket/3073/2013) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, residui: formaldehydum max. 100 µg, octoxinolum-9 max. 500 µg, ovalbuminum max. 0.05 µg, saccharum nihil, neomycinum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Suspension zur Injektion | | | | | | Principe actif | Concentr. |
|---|
| Haemagglutininum Influenzae a (H1N1) (Virus-Stamm A/california/7/2009 (H1N1)-Like: Reassortant Virus nymc X-179a) | 15 µg | | Haemagglutininum Influenzae a (H3N2) (Virus-Stamm A/switzerland/9715293/2013 (H3N2)-Like: Reassortant Virus Ivr-175 Derived from A/south Australia/55/2014) | 15 µg | | Haemagglutininum Influenzae b (Virus-Stamm B/phuket/3073/2013) | 15 µg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Disodium Phosphate Dihydrate | | | | Formaldehydum | 100 µg | residui | | Potassium Chlorure | | | | Potassium Dihydrogenophosphate | | | | Sodium Chlorure | | | | Neomycinum Nihil | | | | Octoxinolum-9 | 500 µg | | | Ovalbuminum | 0.05 µg | | | Saccharum Nihil | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| Aucune entrée n'a été trouvée. |
|
|
